Fosfomycin, antimicrobial activity in vitro and in vivo
- PMID: 401721
- DOI: 10.1159/000222028
Fosfomycin, antimicrobial activity in vitro and in vivo
Abstract
Antibacterial activities of fosfomycin were investigated both in vitro and in vivo for the purpose of comparative evaluation on its fundamental properties with other antimicrobial agents. The MIC was determined with nutrient agar (Difco) inoculated with one loopful of 1,000-fold dilution (about 10(6) cells/ml) of bacterial suspension cultured overnight in nutrient broth. This substance showed antibacterial activity to most gram-positive and gram-negative bacteria, being strongest to Enterobacteriaceae with a peak of the MIC at 1.56 mug/ml in Salmonella. It was also active against P. aeruginosa with a peak of the MIC at 6.25 mug/ml in its sensitivity distribution. Intravenous and subcutaneous fosfomycin Na salt and oral fosfomycin Ca salt were given to 5-week-old ddN strain male mice challenged with clinical isolates of P. aeruginosa, E. coli and P. mirabilis. Therapeutic effect was observed in all these test organisms. In P. aeruginosa, it was more effective than carbenicillin.
Similar articles
-
[Bacteriological studies on fosfomycin. Antibacterial activity in vitro and in vivo (author's transl)].Jpn J Antibiot. 1975 Jun;28(3):320-30. Jpn J Antibiot. 1975. PMID: 807758 Japanese.
-
Newer antibiotic agents acting on gram-negative organisms.Geriatrics. 1973 Aug;28(8):72-6. Geriatrics. 1973. PMID: 4212199 Review. No abstract available.
-
Susceptibility to fosfomycin of hospital strains isolated in Nantes (France). Frequency of mutation to resistance.Chemotherapy. 1977;23 Suppl 1:25-36. doi: 10.1159/000222023. Chemotherapy. 1977. PMID: 401717
-
Evolution of sensitivity to fosfomycin at Jimenez Diaz Foundation.Chemotherapy. 1977;23 Suppl 1:94-8. doi: 10.1159/000222033. Chemotherapy. 1977. PMID: 401722
-
New perspectives for reassessing fosfomycin: applicability in current clinical practice.Rev Esp Quimioter. 2019 May;32 Suppl 1(Suppl 1):1-7. Rev Esp Quimioter. 2019. PMID: 31131586 Free PMC article. Review.
Cited by
-
Molecular Mechanisms and Epidemiology of Fosfomycin Resistance in Staphylococcus aureus Isolated From Patients at a Teaching Hospital in China.Front Microbiol. 2020 Jun 26;11:1290. doi: 10.3389/fmicb.2020.01290. eCollection 2020. Front Microbiol. 2020. PMID: 32670230 Free PMC article.
-
The comparative activity of fosfomycin trometamol against organisms isolated from infected urines.Infection. 1992;20 Suppl 4:S302-4. doi: 10.1007/BF01710019. Infection. 1992. PMID: 1294522
-
[In vitro effect of fosfomycin against Pseudomonas aeruginosa compared to carbenicillin, gentamycin and polymyxin B].Infection. 1978;6(2):73-7. doi: 10.1007/BF01642162. Infection. 1978. PMID: 418008 German.
-
Fosfomycin-ampicillin versus gentamicin-ampicillin in the treatment of critically ill patients with pneumonia.Infection. 1986 Sep-Oct;14(5):246-9. doi: 10.1007/BF01644272. Infection. 1986. PMID: 3641787 Clinical Trial.
-
Immunomodulating effect of fosfomycin on gut-derived sepsis caused by Pseudomonas aeruginosa in mice.Antimicrob Agents Chemother. 1997 Feb;41(2):308-13. doi: 10.1128/AAC.41.2.308. Antimicrob Agents Chemother. 1997. PMID: 9021184 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources